Vrijwillige Transparantie GMP Lentivirale Vector
TED · 539811-2026Voluntary ex-ante transparency noticeawardedNo deadline given
Value
Estimated—
Awarded€1 · 1 EUR
WinnerNetherlands center for the Clinical advancement of Stem cell & Gene Therapies B.V. · KvK 76859134
Who already wins at this buyer
Firms with recorded awards from Leids Universitair Medisch Centrum (LUMC) in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Bruker Nederland B.V. · KvK 35015408 | 2 | — | 2026-07-21 |
| Sebia Benelux SCS | 1 | €1 | 2026-07-30 |
| Siemens Healthineers Nederland B.V. · KvK 92289657 | 1 | €1 | 2026-05-13 |
| Stago BNL B.V. · KvK 28057968 | 1 | €1 | 2026-07-27 |
| Becton Dickinson · KvK 28065261 | 1 | — | 2026-07-03 |
Full buyer profile: what Leids Universitair Medisch Centrum (LUMC) buys and who wins it →
CPV codes
33696500 Medical equipment & pharmaceuticalsBid-check (AI extraction — facts with quotes, not advice)
Description
Vrijwillige Transparantie 20L productie op industriele schaal van GMP Lentivirale vector Batch.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-21 | Vrijwillige Transparantie CosMx, GeoMx en nCounter consumables (L-EU-26-18) | Leids Universitair Medisch Centrum (LUMC) NL | 91% |
| 2026-07-30 | Vrijwillige Transparantie Capillair Elektroforese Systeem | Leids Universitair Medisch Centrum (LUMC) NL | 90% |
| 2026-05-04 | Vrijwillige Transparantie Borealis L-EU-26-05 | Leids Universitair Medisch Centrum (LUMC) NL | 89% |
| 2026-06-18 | Vrijwillige transparantie van een geïntegreerd digitaal opleidingsplatform voor medisch-specialistische zorg | Leids Universitair Medisch Centrum (LUMC) NL | 89% |
| 2026-05-18 | Voluntary Transparency Biomek i3 automated liquid handling platform | Leids Universitair Medisch Centrum (LUMC) NL | 89% |
| 2026-06-11 | Vrijwillige transparantie Massaspectrometer TQ7500+ | Leids Universitair Medisch Centrum (LUMC) NL | 89% |